Keystone Heart Gains Worldwide Exposure!

on .

Keystone Heart’s interview appearance on Worldwide Business with kathy ireland® is set to air worldwide on 2 great stations! What an honor it was to be on this show and now to be rebroadcast for the world to take in.

Data Presented at ACC Demonstrates Benefits of Keystone Heart’s TriGuard™ Cerebral Protection Device during TAVR

on .

Keystone Heart today announced that its CE marked TriGuard™ Cerebral Protection Device has improved in-hospital safety outcomes and cognitive scores at discharge during Transcatheter Aortic Valve Replacement (TAVR). Based on changes in NIH Stroke Scale, patients protected with TriGuard had 10% absolute reduction in stroke (4.9% vs. 14.3%). Minor strokes were under detected without detailed NIHSS assessment.

The TriGuard Cerebral Protection Device is not commercially available in the USA.